Bio Pharma Dive
JANUARY 6, 2021
Partnering with German biotech ViGeneron bolsters Biogen's pipeline of drugs for eye diseases, which includes assets acquired through its buyout of Nightstar Therapeutics.
Pharma Mirror
JANUARY 6, 2021
Infant nutrition, outside of breastfeeding, has become a hot topic recently. Families are taking a hard look at how baby formulas’ ingredients impact their children’s health and development. Concerns and Contamination Every day American parents and caregivers reach for over-the-counter baby formulas and are surprised to find chemicals, additives, and other ingredients that are known to cause health concerns.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JANUARY 6, 2021
A Series B investment in Senti Biosciences will support the startup's research on off-the-shelf candidates, as Bayer places another bet on cell therapy.
World of DTC Marketing
JANUARY 6, 2021
PONTIFICATION: Healthcare agencies need to be the agents of change and lead by example. Speculation or buying into the temporary changes brought on by the pandemic are unrealistic. I just finished reading the latest edition of MedAd News and besides being really dip pointed with the content I was extremely put back by the section on agency people speculating on the changes brought on by the pandemic.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
JANUARY 6, 2021
The biotech, which works in the emerging research field of biomolecular condensates, is teaming up with Pfizer to find new treatments for a rare type of muscular dystrophy.
pharmaphorum
JANUARY 6, 2021
Louis van de Wiel, Vice President, Site Head EU Manufacturing, Kite, a Gilead Company, reveals the complexity that sits behind the process of individualised cell therapy – and why team culture makes it work. This thought leadership series has been paid and developed by Kite, a Gilead Company. In 2018, we were preparing to build a European facility to produce individualised cell therapies for the treatment of cancer.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
pharmaphorum
JANUARY 6, 2021
Pharma companies are always talking about moving ‘beyond the pill’, and Pfizer’s new brand identity embodies that – it’s decades old pill-like logo has been replaced with a DNA double helix that it says reflects its commitment to breakthrough science. The logo – which retains the company’s traditional blue colour scheme – has been more than 18 months in the making and according to the company it is “unlocking the pill to reveal Pfizer’s DNA: the power of science.”.
BioPharma Reporter
JANUARY 6, 2021
AstraZeneca officially announced today the Serum Institute of India, had obtained emergency use authorization in India for its COVID-19 vaccine. It also confirmed the vaccine has been granted emergency use authorization in Argentina, Dominican Republic, El Salvador, Mexico and Morocco.
XTalks
JANUARY 6, 2021
Researchers at the National Institutes of Health (NIH) in the US have isolated small antibodies called “nanobodies” from a llama named Cormac that can block the SARS-CoV-2 coronavirus. One nanobody in particular, called NIH-CoVnb-112, was shown to be able to prevent COVID-19 infection from the novel coronavirus by targeting both the spike protein on SARS-CoV-2, as well as the angiotensin converting enzyme 2 (ACE2) receptor that it binds to on human cells.
BioSpace
JANUARY 6, 2021
NIH Director Francis Collins and David Liu of the Broad Institute have teamed up to conduct a study utilizing CRISPR, the genome-editing system, to see what they could do in terms of altering the aging process in mice.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma Marketing Network
JANUARY 6, 2021
Throughout the year 2020, pharma marketers were forced to explore new strategies in order to keep up with the many evolving trends. Pharma marketers have quickly learned how to adapt to these trends and are prepared to take on new opportunities in 2021. Five trends that will shape the pharma marketing industry in 2021 include media and tech, location independence, relationships despite digital congestion, questioning systems and doubt in institutions, and feelings around trust and wellness.
BioSpace
JANUARY 6, 2021
In the run-up to January’s JP Morgan Healthcare Conference, BioSpace caught up with CEO Paul Wotton to discuss the company’s plans for 2021. More collaborations are key features.
XTalks
JANUARY 6, 2021
The United States Department of Agriculture (USDA) recently announced it will continue its Farmers to Families Food Box program which has already donated more than 100 million food boxes to Americans in response to the COVID-19 pandemic. As part of the fifth round of donations, the USDA pledged to purchase and distribute another $1.5 billion worth of healthy, nutritious food.
BioSpace
JANUARY 6, 2021
Depending on your master’s program of interest and your personal qualifications, you might need to take months (or years) to develop into the type of candidate that is admitted.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
XTalks
JANUARY 6, 2021
Psychedelic drugs are rapidly becoming mainstream as various research supports their effectiveness in alleviating mental health problems. Psychedelic drugs such as LSD, psilocybin, ketamine and more are being studied to explore their effects on mental illnesses, like depression. In the past 10 years, the US has seen a surge in research into the beneficial effects of psychedelic drugs as medicines.
Scienmag
JANUARY 6, 2021
A new review by Swansea University reveals there is widespread belief, around the world, in a teaching method that is not only ineffective but may actually be harmful to learners Credit: Pexels A new review by Swansea University reveals there is widespread belief, around the world, in a teaching method that is not only ineffective […].
BioSpace
JANUARY 6, 2021
ArsenalBio has entered into a multi-year discovery partnership with Bristol Myers Squibb to develop next-generation T cell therapies for solid tumors.
Scienmag
JANUARY 6, 2021
UK survey conducted before and during pandemic also indicates increase in average mental distress for all citizens Credit: Proto E, Quintana-Domeque C (2021) PLOS ONE In the UK, men from ethnic minorities and women may have experienced worse mental health declines than White British men, according to a study published January 6, 2021 in the […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
BioSpace
JANUARY 6, 2021
Process development and quality control will begin in 2021, and full manufacturing capabilities at the 88,000-square-foot facility will be available in 2023.
Scienmag
JANUARY 6, 2021
Funding for device that gives vaccine and monitors response Credit: IMPACT, Swansea University Researchers at Swansea University have received £230,000 to develop the world’s first smart vaccine device that will both deliver the COVID-19 vaccine and measure its efficacy through monitoring the body’s associated response. The research, from the Institute for Innovative Materials, Processing and […].
BioSpace
JANUARY 6, 2021
Although they don’t necessarily agree on numbers, most reports indicate that 2020 was not a particularly good year for mergers and acquisitions in the biopharma industry.
Scienmag
JANUARY 6, 2021
Credit: University of Basel, Biozentrum Writing, driving a screw or throwing darts are only some of the activities that demand a high level of skill. How the brain masters such exquisite movements has now been described in the journal “Nature” by a team of researchers at the University of Basel and the Friedrich Miescher Institute […].
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Pharma Times
JANUARY 6, 2021
Test can give accurate results in under five minutes, according to researchers
Scienmag
JANUARY 6, 2021
Greater conservation efforts are needed to protect the species, which has been affected by human activities at sea Credit: D. Nachtsheim The North Sea is a heavily trafficked area, with major shipping routes crossing its waters, and fisheries, offshore oil rigs, and wind farms populating its waves. All this activity inevitably has an effect on […].
Eye on FDA
JANUARY 6, 2021
Each year in January, it is relevant to look back on the activities of FDA during the course of the previous year and look at how it was the same or different from prior years, and to look at trends in new direction. This past year, needless to say was a doozy on all fronts. Let’s begin by looking at approvals. One might have surmised that the advent of the COVID-era might have thrown off new approvals and that NMEs approved would go diminish.
Scienmag
JANUARY 6, 2021
Taking taboo from those dreaded conversations Credit: Flinders University Our reluctance to think, talk or communicate about death is even more pronounced when we deal with others’ loss compared to our own, new research finds, but either way we tend to frame attitudes and emotions in a sad and negative way. Teaching new more positive […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Delveinsight
JANUARY 6, 2021
In recent decades, apart from the movement of goods and services from one corner of the world to another, globalization has brought many new aspects in its folds. Medical tourism is one of the growing phenomena of the globalized world. In recent years, significant growth has been observed in the medical tourism sector. As a result of the high healthcare cost, people from developed countries move from their home country to another to receive treatment.
Scienmag
JANUARY 6, 2021
Proteins engineered to form honeycomb structures can block uptake of receptors from the surface of cells Credit: Ian Haydon, UW Medicine Institute for Protein Design A new class of protein material that interacts with living cells without being absorbed by them can influence cell signaling, a new study shows. The material does this by binding […].
BioSpace
JANUARY 6, 2021
This week multiple companies have announced millions of investment dollars have flooded their coffers to advance research and development of multiple therapies. BioSpace is rounding up the announcements.
Scienmag
JANUARY 6, 2021
Credit: University of Ottawa A study led by University of Ottawa researchers provides empirical evidence that mindfulness has a significant impact on the brain of women suffering from neuropathic pain related to breast cancer treatment. The researchers showed that mindfulness-based stress reduction (MBSR) helps modulate neuropathic pain. Their findings could make a difference in the […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
306 
Let's personalize your content